Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma - Wikidata - wikimedia - TriplyDB

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

http://www.wikidata.org/entity/Q28262173

about

Notch signalling pathway as an oncogenic factor involved in cancer development Jagged1 (JAG1): Structure, expression, and disease associations Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.Lateral inhibition of Notch signaling in neoplastic cells.Withanolides are potent novel targeted therapeutic agents against adrenocortical carcinomas.Notch signaling molecules as prognostic biomarkers for non-small cell lung cancer.Guzhi Zengsheng Zhitongwan, a Traditional Chinese Medicinal Formulation, Stimulates Chondrocyte Proliferation through Control of Multiple Genes Involved in Chondrocyte Proliferation and Differentiation

P2860

Q28072977-3824ED64-5851-4834-89D6-000FA0D1BEE1 Q28606584-EFDB791A-86ED-4771-BD0D-A782163A513F Q33572313-E29A6182-5D74-445C-A169-2069E37A6B7D Q34552896-77AA4BFE-1E8D-4A04-BB8C-DAE5F29511B8 Q38923462-BAC13EBE-5A3A-4777-8731-2E8ADEB95F8B Q39203872-9435B8AB-D18F-4E8C-ADB7-2AFBC9A02AFB Q40153305-1408AE38-AD9F-4935-95F7-267E235E2D34 Q57112342-7EDCA029-5796-4022-B455-0FF3EEF5CEF3

P2860

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

http://www.wikidata.org/entity/Q28262173

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

@ast

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

@en

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

@nl

type

label

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

@ast

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

@en

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

@nl

prefLabel

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

@ast

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

@en

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

@nl

P1433

Q28262173-601FBEE7-430C-4159-8A3D-9C65D6635513

P1476

Q28262173-2BCD16C6-52EF-4F16-AB60-DCAAFBBF0F95

P2093

Q28262173-373566C7-C2E3-486E-9C79-365AB5592902

Q28262173-9746A582-B324-438E-9A73-04C0637ADF29

P2860

Q28262173-03EFC9B2-4EA6-45E5-AA30-4B94927C3269

Q28262173-06C290A9-481D-46E9-8D6D-76B9A8C54D44

Q28262173-09D1A4E8-1E8B-4D8A-BAF3-0FF39379925B

Q28262173-0B5EE386-FAB1-4573-937D-51319BC3C3E2

Q28262173-0C55035A-9455-4CED-A10C-AD224B5F9DC1

Q28262173-1403E832-CC79-4DA1-BC53-54ADA176004C

Q28262173-14D3F62D-28AD-422D-968D-21B1CAE0FCAB

Q28262173-19A97FD7-96B2-4E08-B96E-DCF1C92C7870

Q28262173-1C3B6730-33C4-4572-9633-00B9FF8E23CD

Q28262173-1F5DA99C-0DF6-40AE-877A-90624AB513F1

P304

Q28262173-B8DA725C-332C-45E1-BCCE-BDA37A7E90F2

P31

Q28262173-62CF594D-87AB-465F-91D7-303624138289

P3181

Q28262173-A28742C2-EE4B-4B03-963B-B1C82883B372

P356

Q28262173-63EF12C1-6EE7-4AB5-804E-599A0E1A8033

P407

Q28262173-0EB8F885-4636-4F75-A06C-498C588195F9

P433

Q28262173-1DF30DCA-E531-4BDA-B3C6-851E9C8A5263

P478

Q28262173-CA4E4F26-833A-4955-A7D2-FFF82914A841

P50

Q28262173-0E2BCFE8-BB89-448E-A215-85BC4B973D90

P577

Q28262173-A33550C3-080A-4609-80E7-A49D0DD3EBE7

P698

Q28262173-EFFFADD4-C92C-4258-83F9-F5A24A310E24

P932

Q28262173-91230F77-A20A-4F1B-BD37-D76CF8F4E92F

P3181

P356

1078-0432.CCR-11-2371

P1433

Clinical Cancer Research

P1476

Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma

@en

P2093

Derek P Simon

http://www.w3.org/2001/XMLSchema#string

Gary D Hammer

http://www.w3.org/2001/XMLSchema#string

P2860

Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin.

Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism

Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2

The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments

High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival

High-level JAG1 mRNA and protein predict poor outcome in breast cancer

The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands

Calcium depletion dissociates and activates heterodimeric notch receptors

The canonical Notch signaling pathway: unfolding the activation mechanism.

Notch signalling: a simple pathway becomes complex

P304

2452-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3675326

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-11-2371

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Giordano

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22427350

http://www.w3.org/2001/XMLSchema#string

P932

3848076

http://www.w3.org/2001/XMLSchema#string